Compare CDXS & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDXS | FNWD |
|---|---|---|
| Founded | 2002 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Savings Institutions |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.8M | 154.0M |
| IPO Year | 2010 | N/A |
| Metric | CDXS | FNWD |
|---|---|---|
| Price | $1.72 | $34.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | ★ 986.3K | 15.2K |
| Earning Date | 02-26-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 1.37% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | $52,932,000.00 | ★ $66,563,999.00 |
| Revenue This Year | $15.64 | N/A |
| Revenue Next Year | $5.23 | $8.03 |
| P/E Ratio | ★ N/A | $18.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.52 | $26.12 |
| 52 Week High | $5.43 | $39.99 |
| Indicator | CDXS | FNWD |
|---|---|---|
| Relative Strength Index (RSI) | 51.09 | 44.80 |
| Support Level | $1.61 | $34.54 |
| Resistance Level | $1.74 | $35.36 |
| Average True Range (ATR) | 0.06 | 0.92 |
| MACD | 0.02 | -0.13 |
| Stochastic Oscillator | 84.38 | 44.29 |
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.